No news anytime soon on Sandoz sale, says Novartis | pharmaphorum
Novartis Will Spin Off Sandoz Generic-Drugs Unit by Next Year - BNN Bloomberg
Novartis AG To Spin-Off Sandoz Business In 4Q23
Novartis segregará Sandoz en 2023 para crear el mayor laboratorio de genéricos | Empresas | Cinco Días
Novartis and Sandoz withdraw medicines from US over packaging concerns - Pharmaceutical Technology
A history of Novartis | pharmaphorum
Novartis Stock: Don't Rush Buying This Swiss Quality Business | Seeking Alpha
Novartis May Turn Sandoz into Separate Entity Amidst Restructuring | BioSpace
Blackstone, Carlyle Mull Joint Bid for Novartis Generics Arm - Bloomberg
/cloudfront-us-east-2.images.arcpublishing.com/reuters/UQPIK3T2DVOX7EIO4QZCM5HIAA.jpg "Novartis' Sandoz wagers its standalone future on biosimilar success | Reuters")
Novartis' Sandoz wagers its standalone future on biosimilar success | Reuters
novartis: Novartis to spin off generics biz sandoz - The Economic Times
Novartis' Sandoz drops out of prescription app deal with Pear Therapeutics | Fierce Biotech
Swiss pharma's big bet on Slovenia - SWI swissinfo.ch
Novartis plans Sandoz spin-off around Oct. 4, proposes share distribution | Reuters
Novartis Weighs Sale or Spinoff of Generic Drug Unit Sandoz - WSJ
Sandoz acquires UK-based drug delivery device firm Coalesce | HealthCare Middle East & Africa Magazine
Novartis weighs sale of ophthalmology, respiratory units, Health News, ET HealthWorld
Novartis to list its subsidiary Sandoz on the stock exchange - BioAlps
Sandoz launches rival version of AbbVie's arthritis drug Humira
/cloudfront-us-east-2.images.arcpublishing.com/reuters/5DHA7FK4SRKA7K4CSVPZCIDJQ4.jpg "Novartis to spin off generics business Sandoz next year | Reuters")
Novartis to spin off generics business Sandoz next year | Reuters
Novartis' spin-off of Sandoz business
Novartis to spin off generics business Sandoz next year
Sandoz through the years - Novartis Live. Magazine
Novartis To Spinoff Sandoz Business To Create #1 European Generics Company
